The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. Elsevier’s Current Opinion journals comprise of 26 leading titles in life sciences and adjacent fields.

Current Opinion in Toxicology

Issues per year: 6 issues
Editorial Board

Current Opinion in Toxicology

The aims and scope of Current Opinion in Toxicology is to systematically provide the reader with timely and provocative views and opinions of the highest qualified and recognized experts on current advances in selected topics within the field of toxicology. The goal is that Current Opinion in Toxicology will be an invaluable source of information and perspective for researchers, teachers, managers and administrators, policy makers and students.

Division of the subject into sections:

For this purpose, the scope of Toxicology is divided into six selected high impact themed sections, each of which is reviewed once a year:

  • Mechanistic Toxicology
  • Metabolic Toxicology
  • Risk assessment in Toxicology
  • Genomic Toxicology
  • Systems Toxicology
  • Translational Toxicology

Best Cited over the last year.

Subscribe to RSS Sciverse Scopus

The multifaceted role of Nrf2 in mitochondrial function

Volume 2, Issue , 01 January 2017, Pp 80-91
Kira M. Holmström | Rumen V. Kostov | Albena T. Dinkova-Kostova

Diversity as opportunity: Insights from 600 million years of AHR evolution

Volume 2, Issue , 01 January 2017, Pp 58-71
Mark E. Hahn | Sibel I. Karchner | Rebeka R. Merson

And now for something completely different: Diversity in ligand-dependent activation of Ah receptor responses

Volume 2, Issue , 01 February 2017, Pp 124-131
Michael S. Denison | Samantha C. Faber

The aryl hydrocarbon receptor (AhR) as a drug target for cancer chemotherapy

Volume 1, Issue , 01 January 2016, Pp 24-29
Stephen Safe | Yating Cheng | Un Ho Jin

Shadows of NRF2 in cancer: Resistance to chemotherapy

Volume 1, Issue , 01 January 2016, Pp 20-28
Bo hyun Choi | Mi Kyoung Kwak

Gene regulatory effects of disease-associated variation in the NRF2 network

Volume 1, Issue , 01 January 2016, Pp 71-79
Sarah E. Lacher | Matthew Slattery

Roles of Nrf2 in drug and chemical toxicity

Volume 1, Issue , 01 January 2016, Pp 104-110
Jessica L. Clarke | James B. Murray | B. Kevin Park | Ian M. Copple

Progress in identifying epigenetic mechanisms of xenobiotic-induced non-genotoxic carcinogenesis

Volume 3, Issue , 01 April 2017, Pp 62-70
Rémi Terranova | Antonio Vitobello | Alberto Del Rio Espinola | C. Roland Wolf | Michael Schwarz | John Thomson | Richard Meehan | Jonathan Moggs

Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immune-mediated diseases?

Volume 2, Issue , 01 January 2017, Pp 72-78
Allison K. Ehrlich | Nancy I. Kerkvliet

The relevance of experimental carcinogenicity studies to human safety

Volume 3, Issue , 01 April 2017, Pp 6-11
Samuel M. Cohen

The diverse and important contributions of the AHR to cancer and cancer immunity

Volume 2, Issue , 01 January 2017, Pp 93-102
Zhongyan Wang | Stefano Monti | David H. Sherr

Regulation of Keap1–Nrf2 signaling: The role of epigenetics

Volume 1, Issue , 01 January 2016, Pp 134-138
David Cheng | Renyi Wu | Yue Guo | Ah Ng Tony Kong

The complex role of NRF2 in cancer: A genomic view

Volume 1, Issue , 01 January 2016, Pp 37-45
Brandon John Praslicka | Michael John Kerins | Aikseng Ooi

Overview of redox regulation by Keap1–Nrf2 system in toxicology and cancer

Volume 1, Issue , 01 January 2016, Pp 29-36
Mikiko Suzuki | Akihito Otsuki | Nadine Keleku-Lukwete | Masayuki Yamamoto

Regulation of the Keap1–Nrf2 pathway by p62/SQSTM1

Volume 1, Issue , 01 January 2016, Pp 54-61
Yoshinori Katsuragi | Yoshinobu Ichimura | Masaaki Komatsu

Molecular modeling of the AhR structure and interactions can shed light on ligand-dependent activation and transformation mechanisms

Volume 1, Issue , 01 January 2016, Pp 42-49
Laura Bonati | Dario Corrada | Sara Giani Tagliabue | Stefano Motta

Ligand activation of the Ah receptor contributes to gastrointestinal homeostasis

Volume 1, Issue , 01 January 2016, Pp 15-23
Iain A. Murray | Gary H. Perdew

Contact hypersensitivity: Integrated approaches to testing and assessment

Volume 5, Issue , 01 August 2017, Pp 1-5
Silvia Casati

Air pollution and the epigenome: A model relationship for the exploration of toxicoepigenetics

Volume 6, Issue , 01 October 2017, Pp 18-25
Shaun D. McCullough | Radhika Dhingra | Marie C. Fortin | David Diaz-Sanchez

Retinoic acid-related orphan receptor γ (RORγ): Connecting sterol metabolism to regulation of the immune system and autoimmune disease

Volume 8, Issue , 01 April 2018, Pp 66-80
Anton M. Jetten | Yukimasa Takeda | Andrzej Slominski | Hong Soon Kang

Canonical and non-canonical aryl hydrocarbon receptor signaling pathways

Volume 2, Issue , 01 January 2017, Pp 87-92
Eric J. Wright | Karen Pereira De Castro | Aditya D. Joshi | Cornelis J. Elferink

The aryl hydrocarbon receptor as a moderator of host-microbiota communication

Volume 2, Issue , 01 January 2017, Pp 30-35
Limin Zhang | Robert G. Nichols | Andrew D. Patterson

Does the aryl hydrocarbon receptor regulate pluripotency?

Volume 2, Issue , 01 January 2017, Pp 1-7
Chia I. Ko | Alvaro Puga

NQO1 in protection against oxidative stress

Volume 7, Issue , 01 February 2018, Pp 67-72
David Ross | David Siegel